Clinical Trial Update: Treatment Resistant Depression in America Latina

View source ↗

Summary

This clinical trial update reports that a Janssen-sponsored study on treatment-resistant depression conducted in Latin America has reached completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• SPRAVATO (ESKETAMINE HYDROCHLORIDE)

Snippet

Sponsor: Janssen-Cilag, S.A. | Conditions: Depressive Disorder, Treatment-Resistant | Status: COMPLETED